Arsenic Trioxide: Pharmacological Applications

Arsenic trioxide induces macrophage autophagy and atheroprotection by regulating ROS-dependent TFEB nuclear translocation and AKT/mTOR pathway

(2021) Shaohong Fang et al.   Cell Death & Disease

Effect of arsenic trioxide on the Tregs ratio and the levels of IFN-γ, IL-4, IL-17 and TGF-β1 in the peripheral blood of severe aplastic anemia patients

(2020) Juanjuan Zhao et al.   MEDICINE

Balance between the toxicity and anticancer activitiy of arsenic trioxide in treatment of acute promyelocytic leukemia

(2020) Qian Qian Wang et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet

(2019) Miguel A. Sanz et al.   BLOOD

Pre-application of arsenic trioxide may potentiate cytotoxic effects of vinorelbine/docetaxel on neuroblastoma SK-N-SH cells

(2019) Kai Qi et al.   BIOMEDICINE & PHARMACOTHERAPY

Arsenic Trioxide Impacts Viral Latency and Delays Viral Rebound after Termination of ART in Chronically SIV‐Infected Macaques

(2019) Qing Yang et al.   Advanced Science

Origin and initiation mechanisms of neuroblastoma

(2018) Shoma Tsubota et al.   CELL AND TISSUE RESEARCH

Arsenic trioxide: insights into its evolution to an anticancer agent

(2018) Maneka Hoonjan et al.   JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY

The optimal dose of arsenic trioxide induced opposite efficacy in autophagy between K562 cells and their initiating cells to eradicate human myelogenous leukemia

(2017) Zhenzhen Guo et al.   JOURNAL OF ETHNOPHARMACOLOGY

Effects of arsenic trioxide on the expression of ezrin in hepatocellular carcinoma

(2017) Wei Lu et al.   MEDICINE

Long-term outcome of acute promyelocytic leukemia treated with all- trans -retinoic acid, arsenic trioxide, and gemtuzumab

(2016) Yasmin Abaza et al.   BLOOD

A Meta-Analysis of Arsenic Trioxide Combined with Transcatheter Arterial Chemoembolization for Treatment of Primary Hepatic Carcinoma

(2016) Ling He et al.   Evidence-based Complementary and Alternative Medicine

Arsenic trioxide regulates adipogenic and osteogenic differentiation in bone marrow MSCs of aplastic anemia patients throughBMP4gene

(2015) Huan Chen Cheng et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Neuroblastoma and nephroblastoma: a radiological review

(2015) Maureen Dumba et al.   CANCER IMAGING

Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial

(2015) Harry J Iland et al.   Lancet Haematology

Acute promyelocytic leukemia: What is the new standard of care?

(2014) Justin M. Watts et al.   BLOOD REVIEWS

Arsenic trioxide transarterial chemoembolization with and without additional intravenous administration of arsenic trioxide in unresectable hepatocellular carcinoma with lung metastasis: a single-blind, randomized trial

(2014) Bing Liu et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Microambiente medular en la leucemia mieloide crónica: su relación con la enfermedad y la respuesta al tratamiento

(2014) José Alejandro Aristizábal et al.   REVISTA MEDICA DE CHILE

Arsenic trioxide-based therapy in relapsed/refractory multiple myeloma patients: a meta-analysis and systematic review

(2014) Xuepeng He et al.   OncoTargets and Therapy

Arsenic trioxide inhibits the proliferation of myeloma cell line through notch signaling pathway

(2013) Jiasheng Hu et al.   Cancer Cell International

VEGF depletion enhances bcr-abl-specific sensitivity of arsenic trioxide in chronic myelogenous leukemia

(2013) Xiaochuang Luo et al.   Hematology

Effective targeting of chronic myeloid leukemia initiating activity with the combination of arsenic trioxide and interferon alpha

(2013) Rabab M. El Eit et al.   INTERNATIONAL JOURNAL OF CANCER

Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia

(2013) Francesco Lo-Coco et al.   NEW ENGLAND JOURNAL OF MEDICINE

Toward a therapeutic reduction of imatinib refractory myeloproliferative neoplasm-initiating cells

(2013) S T Philips et al.   ONCOGENE

Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia

(2012) Ning Li et al.   Journal of Hematology & Oncology

Arsenic Trioxide Enhances the Radiation Sensitivity of Androgen-Dependent and -Independent Human Prostate Cancer Cells

(2012) Hui-Wen Chiu et al.   PLoS One

Tratamiento con trióxido de arsénico en paciente con recaída de leucemia promielocítica aguda

(2010) M.L. Moreno Tejero et al.   ANALES DE PEDIATRIA

Arsenic trioxide — An old drug rediscovered

(2010) Ashkan Emadi et al.   BLOOD REVIEWS

Diagnóstico y tratamiento del carcinoma hepatocelular

(2009) Alejandro Forner et al.   MEDICINA CLINICA